Literature DB >> 8834577

Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer.

P H Sugarbaker1.   

Abstract

Advanced primary and recurrent ovarian cancer within the pelvis presents a difficult oncologic problem in management. Based on a failure analysis of ovarian cancer, a new procedure was devised for the complete surgical removal of all visceral and parietal pelvic surfaces. Resections included the uterus, ovaries, rectosigmoid colon, and the complete pelvic peritoneum, including the cul-de-sac of Douglas. An immediate low rectal anastomosis with a circular stapler was utilized in all patients. Intraperitoneal chemotherapy was employed on postoperative days 1-5 to prevent further implantation of cancer cells. The technical experience with 12 women is reported. The circular stapler resulted in no anastomotic leakage and no anastomotic bleeding. There were no postoperative deaths. These results suggest that complete pelvic peritonectomy combined with early postoperative intraperitoneal chemotherapy carries an acceptable morbidity and mortality, and is a new treatment strategy that may be considered for advanced malignancy in the pelvic cavity. This surgical technique may be pursued in an attempt to optimize the management of ovarian cancer with peritoneal seeding.

Entities:  

Mesh:

Year:  1996        PMID: 8834577     DOI: 10.1007/978-1-4613-1245-1_8

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  10 in total

Review 1.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 2.  En bloc pelvic resection of ovarian cancer with rectosigmoid colectomy: a literature review.

Authors:  Myeong-Seon Kim; Joseph J Noh; Yoo-Young Lee
Journal:  Gland Surg       Date:  2021-03

3.  Cytoreductive surgery and HIPEC in peritoneal recurrent ovarian cancer: experience and lessons learned.

Authors:  Ingmar Königsrainer; Stefan Beckert; Sven Becker; Derek Zieker; Tanja Fehm; Eva-Maria Grischke; Olivia Lauk; Jörg Glatzle; Björn Brücher; Diethelm Wallwiener; Alfred Königsrainer
Journal:  Langenbecks Arch Surg       Date:  2011-08-13       Impact factor: 3.445

4.  Relation between type of hysterectomy and survival rate in patients with ovarian cancer - single-center study.

Authors:  Stanislav Slavchev; Stoyan Kostov; Strahil Strashilov; Angel Yordanov
Journal:  Prz Menopauzalny       Date:  2020-10-02

Review 5.  Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals.

Authors:  F C Muñoz-Casares; S Rufián; M J Rubio; E Lizárraga; C Díaz-Iglesias; E Aranda; R Ciria; J Muntané; P Barrios; J Torres-Melero; S González-Moreno; L González-Bayón; B Camps; P Bretcha; J Farré; G Ortega-Pérez; A Gómez-Portilla
Journal:  Clin Transl Oncol       Date:  2007-10       Impact factor: 3.405

6.  The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer.

Authors:  Francisco C Muñoz-Casares; Sebastián Rufián; María J Rubio; Carlos J Díaz; Rafael Díaz; Angela Casado; Alvaro Arjona; María C Muñoz-Villanueva; Jordi Muntané
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

7.  Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies.

Authors:  Krishnansu S Tewari
Journal:  Gynecol Oncol Res Pract       Date:  2016-10-24

8.  Rectosigmoid sparing en bloc pelvic resection for fixed ovarian tumors: Surgical technique and perioperative and oncologic outcomes.

Authors:  Ying Shan; Ying Jin; Yan Li; Yu Gu; Wei Wang; Lingya Pan
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

9.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer.

Authors:  Pompiliu Piso; Marc-Hendrik Dahlke; Martin Loss; Hans Juergen Schlitt
Journal:  World J Surg Oncol       Date:  2004-06-28       Impact factor: 2.754

10.  Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC.

Authors:  S P Somashekhar; K R Ashwin; Ramya Yethadka; Shabber S Zaveri; Vijay K Ahuja; Amit Rauthan; Kumar C Rohit
Journal:  Pleura Peritoneum       Date:  2019-11-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.